2-[3-bromo-7-[[1-(oxan-4-yl)piperidin-3-yl]methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]phenol
C23H28BrN5O2 — CID 143441919
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-bromo-7-[[1-(oxan-4-yl)piperidin-3-yl]methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]phenol
2-[3-bromo-7-[[1-(oxan-4-yl)piperidin-3-yl]methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]phenol (PubChem CID 143441919) has the molecular formula C23H28BrN5O2 and a molecular weight of 486.41 g/mol. Its IUPAC name is 2-[3-bromo-7-[[1-(oxan-4-yl)piperidin-3-yl]methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]phenol.
Molecular Properties
| Compound Name | 2-[3-bromo-7-[[1-(oxan-4-yl)piperidin-3-yl]methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]phenol |
|---|---|
| PubChem CID | 143441919 |
| Molecular Formula | C23H28BrN5O2 |
| Molecular Weight | 486.41 g/mol |
| Exact Mass | 485.14 |
| IUPAC Name | 2-[3-bromo-7-[[1-(oxan-4-yl)piperidin-3-yl]methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]phenol |
| SMILES | Oc1ccccc1-c1cc(NCC2CCCN(C3CCOCC3)C2)n2ncc(Br)c2n1 |
| InChI | InChI=1S/C23H28BrN5O2/c24-19-14-26-29-22(12-20(27-23(19)29)18-5-1-2-6-21(18)30)25-13-16-4-3-9-28(15-16)17-7-10-31-11-8-17/h1-2,5-6,12,14,16-17,25,30H,3-4,7-11,13,15H2 |
| InChIKey | NAIVQDAYYSWCGE-UHFFFAOYSA-N |
| XLogP | 4.17 |
| TPSA | 74.92 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.41 |
| LogP ≤ 5 | 4.17 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143441919 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.